These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 34019262)
1. Inflammatory Pathways in Sarcoidosis. Barna BP; Judson MA; Thomassen MJ Adv Exp Med Biol; 2021; 1304():39-52. PubMed ID: 34019262 [TBL] [Abstract][Full Text] [Related]
2. Studies in a Murine Granuloma Model of Instilled Carbon Nanotubes: Relevance to Sarcoidosis. Barna BP; Malur A; Thomassen MJ Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918196 [TBL] [Abstract][Full Text] [Related]
3. [Granulomatous diseases and pathogenic microorganism]. Inoue Y; Suga M Kekkaku; 2008 Feb; 83(2):115-30. PubMed ID: 18326339 [TBL] [Abstract][Full Text] [Related]
4. Peroxisome Proliferator-activated Receptor-γ Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis Model. Malur A; Mohan A; Barrington RA; Leffler N; Malur A; Muller-Borer B; Murray G; Kew K; Zhou C; Russell J; Jones JL; Wingard CJ; Barna BP; Thomassen MJ Am J Respir Cell Mol Biol; 2019 Aug; 61(2):198-208. PubMed ID: 30741559 [TBL] [Abstract][Full Text] [Related]
5. PPAR-gamma pathways attenuate pulmonary granuloma formation in a carbon nanotube induced murine model of sarcoidosis. McPeek M; Malur A; Tokarz DA; Murray G; Barna BP; Thomassen MJ Biochem Biophys Res Commun; 2018 Sep; 503(2):684-690. PubMed ID: 29908181 [TBL] [Abstract][Full Text] [Related]
6. Matrix Metalloproteinase-12 Is Required for Granuloma Progression. Mohan A; Neequaye N; Malur A; Soliman E; McPeek M; Leffler N; Ogburn D; Tokarz DA; Knudson W; Gharib SA; Schnapp LM; Barna BP; Thomassen MJ Front Immunol; 2020; 11():553949. PubMed ID: 33072094 [TBL] [Abstract][Full Text] [Related]
8. New concepts in the pathogenesis of sarcoidosis. Bennett D; Bargagli E; Refini RM; Rottoli P Expert Rev Respir Med; 2019 Oct; 13(10):981-991. PubMed ID: 31414923 [No Abstract] [Full Text] [Related]
9. Molecular Mechanism in the Development of Pulmonary Fibrosis in Patients with Sarcoidosis. Cocconcelli E; Bernardinello N; Castelli G; Petrarulo S; Bellani S; Saetta M; Spagnolo P; Balestro E Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445947 [TBL] [Abstract][Full Text] [Related]
10. Th17-lineage cells in pulmonary sarcoidosis and Löfgren's syndrome: Friend or foe? Miedema JR; Kaiser Y; Broos CE; Wijsenbeek MS; Grunewald J; Kool M J Autoimmun; 2018 Feb; 87():82-96. PubMed ID: 29310925 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary granulomatous inflammation: From sarcoidosis to tuberculosis. Perez RL; Rivera-Marrero CA; Roman J Semin Respir Infect; 2003 Mar; 18(1):23-32. PubMed ID: 12652451 [TBL] [Abstract][Full Text] [Related]
12. Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Chen ES; Song Z; Willett MH; Heine S; Yung RC; Liu MC; Groshong SD; Zhang Y; Tuder RM; Moller DR Am J Respir Crit Care Med; 2010 Feb; 181(4):360-73. PubMed ID: 19910611 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Limper AH; Colby TV; Sanders MS; Asakura S; Roche PC; DeRemee RA Am J Respir Crit Care Med; 1994 Jan; 149(1):197-204. PubMed ID: 8111583 [TBL] [Abstract][Full Text] [Related]
14. The pathology of pulmonary sarcoidosis: update. Ma Y; Gal A; Koss MN Semin Diagn Pathol; 2007 Aug; 24(3):150-61. PubMed ID: 17882899 [TBL] [Abstract][Full Text] [Related]
15. Depressed peroxisome proliferator-activated receptor gamma (PPargamma) is indicative of severe pulmonary sarcoidosis: possible involvement of interferon gamma (IFN-gamma). Barna BP; Culver DA; Abraham S; Malur A; Bonfield TL; John N; Farver CF; Drazba JA; Raychaudhuri B; Kavuru MS; Thomassen MJ Sarcoidosis Vasc Diffuse Lung Dis; 2006 Jun; 23(2):93-100. PubMed ID: 17937104 [TBL] [Abstract][Full Text] [Related]
16. Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis. Ten Berge B; Paats MS; Bergen IM; van den Blink B; Hoogsteden HC; Lambrecht BN; Hendriks RW; Kleinjan A Rheumatology (Oxford); 2012 Jan; 51(1):37-46. PubMed ID: 22075064 [TBL] [Abstract][Full Text] [Related]
17. Strategies for identifying pulmonary sarcoidosis patients at risk for severe or chronic disease. Judson MA Expert Rev Respir Med; 2017 Feb; 11(2):111-118. PubMed ID: 28076979 [TBL] [Abstract][Full Text] [Related]
18. The Pathogenesis of Pulmonary Sarcoidosis and Implications for Treatment. Patterson KC; Chen ES Chest; 2018 Jun; 153(6):1432-1442. PubMed ID: 29224832 [TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis. Christophi GP; Caza T; Curtiss C; Gumber D; Massa PT; Landas SK Exp Mol Pathol; 2014 Jun; 96(3):393-9. PubMed ID: 24768588 [TBL] [Abstract][Full Text] [Related]
20. Apoptosis in the course of granulomatous inflammation in pulmonary sarcoidosis. Kunitake R; Kuwano K; Miyazaki H; Hagimoto N; Nomoto Y; Hara N Eur Respir J; 1999 Jun; 13(6):1329-37. PubMed ID: 10445608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]